Cargando…

Integrated care model and point of care diagnostics facilitate Hepatitis C treatment among patients receiving opioid agonist therapy: a retrospective review of medical records

BACKGROUND: Hepatitis C virus (HCV) is common among individuals in opioid agonist therapy (OAT). HCV treatment has previously been unavailable for most HCV positive OAT patients in Finland. The removal of treatment restrictions and attempts to reach HCV elimination goals have increased the number of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Häkkinen, Margareeta, Tourunen, Jouni, Pitkänen, Tuuli, Simojoki, Kaarlo, Vuoti, Sauli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161480/ https://www.ncbi.nlm.nih.gov/pubmed/35655277 http://dx.doi.org/10.1186/s13011-022-00473-3

Ejemplares similares

From controlled opioid substitution treatment to pharmacy delivery of buprenorphine-naloxone and to treatment in primary health care: the views of patients and personnel
por: Tourunen, Jouni, et al.
Publicado: (2010)

Past-year gambling behaviour among patients receiving opioid substitution treatment
por: Castrén, Sari, et al.
Publicado: (2015)

Standards for opioid use disorder care: An assessment of Nordic approaches
por: Gedeon, Charlotte, et al.
Publicado: (2019)

A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
por: Simojoki, Kaarlo, et al.
Publicado: (2008)

Expanding access to hepatitis C treatment by improving linkage to care: Establishing a cascade of care and active linkage program for the South Karelia region in Finland
por: Kemppinen, Juha, et al.
Publicado: (2020)

Retrospective, Registry-based, Cohort Investigation of Clinical Outcomes in Patients with Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma in Finland
por: TUOMINEN, Samuli, et al.
Publicado: (2022)

Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment
por: Marchand, Kirsten, et al.
Publicado: (2020)

Non-fatal overdose risk during and after opioid agonist treatment: A primary care cohort study with linked hospitalisation and mortality records
por: Domzaridou, Eleni, et al.
Publicado: (2022)

Access to Primary Care Clinics for Patients With Chronic Pain Receiving Opioids
por: Lagisetty, Pooja A., et al.
Publicado: (2019)

Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping review
por: Leece, Pamela, et al.
Publicado: (2019)

Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review
por: Pijl, Em M., et al.
Publicado: (2022)

Point of care microspirometry to facilitate the COPD diagnostic process in primary care: a clustered randomised trial
por: Schermer, Tjard R., et al.
Publicado: (2018)

Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study
por: Bech, Anne Berit, et al.
Publicado: (2019)

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy
por: Feng, Hwa‐Ping, et al.
Publicado: (2018)

Quality of care for OA: the effect of a point-of-care consultation recording template
por: Edwards, John J., et al.
Publicado: (2015)

QT interval prolongation in opioid agonist treatment: analysis of continuous 12‐lead electrocardiogram recordings
por: Isbister, Geoffrey K., et al.
Publicado: (2017)

Effect of an Electronic Health Record “Nudge” on Opioid Prescribing and Electronic Health Record Keystrokes in Ambulatory Care
por: Ancker, Jessica S., et al.
Publicado: (2020)

Feasibility of alcohol screening among patients receiving opioid treatment in primary care
por: Henihan, Anne Marie, et al.
Publicado: (2016)

Evaluating comparative effectiveness of psychosocial interventions for persons receiving opioid agonist therapy for opioid use disorder: protocol for a systematic review
por: Rice, Danielle B, et al.
Publicado: (2018)

Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Point-of-Care Diagnostics
por: Yetisen, Ali Kemal
Publicado: (2014)

(E)-1-(4-Aminophenyl)ethanone oxime
por: Rafiq, Muhammad, et al.
Publicado: (2008)

Barriers and facilitators to implementing changes in opioid prescribing in rural primary care clinics
por: Parchman, Michael L., et al.
Publicado: (2020)

Barriers and Facilitators to Point-of-Care Ultrasound Use in Rural Australia
por: Arnold, Annie C., et al.
Publicado: (2023)

Pregnant Smokers Receiving Opioid Agonist Therapy Have an Elevated Nicotine Metabolite Ratio: A Replication Study
por: Kranzler, Henry R, et al.
Publicado: (2020)

Intraosseous blood samples for point-of-care analysis: agreement between intraosseous and arterial analyses
por: Jousi, Milla, et al.
Publicado: (2017)

Alcohol use in opioid agonist treatment
por: Nolan, Seonaid, et al.
Publicado: (2016)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

The association between different opioid doses and the survival of advanced cancer patients receiving palliative care
por: Sathornviriyapong, Anon, et al.
Publicado: (2016)

Cancer Patients' Perceived Difficulties Filling Opioid Prescriptions After Receiving Outpatient Supportive Care
por: Brown, Jessica H., et al.
Publicado: (2020)

Tubular cell damage may be the earliest sign of renal extrahepatic manifestation caused by Hepatitis C
por: Kaartinen, Kati, et al.
Publicado: (2021)

Interim opioid agonist treatment for opioid addiction: a systematic review
por: Samsó Jofra, Laura, et al.
Publicado: (2022)

Qualitative analysis of stakeholder interviews to identify the barriers and facilitators to the adoption of point-of-care diagnostic tests in the UK
por: Huddy, Jeremy R, et al.
Publicado: (2021)

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy
por: Feng, Hwa‐Ping, et al.
Publicado: (2018)

Impact of Home Care Admission Nurses' Goals on Electronic Health Record Documentation Strategies at the Point of Care
por: Yang, Yushi, et al.
Publicado: (2019)

Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting
por: Seidenberg, André, et al.
Publicado: (2013)

Evaluation of the Serological Point-of-Care Testing of Infectious Mononucleosis by Data of External Quality Control Samples
por: Kiiskinen, Salla J, et al.
Publicado: (2020)

Principles for managing OUD related to chronic pain in the Nordic countries based on a structured assessment of current practice
por: Kakko, Johan, et al.
Publicado: (2018)

Deimplementation in the provision of opioid agonist treatment to achieve equity of care for people engaged in treatment: a qualitative study
por: Conway, Anna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q90v0gnlqqntqbqm5sdmt0a5a6